Journal of Vascular and Interventional Radiology
Volume 20, Issue 7, Supplement , Pages S240-S249 , July 2009

Consensus Guidelines for Periprocedural Management of Coagulation Status and Hemostasis Risk in Percutaneous Image-guided Interventions

  • Patrick C. Malloy, MD

      Affiliations

    • Division of Vascular and Interventional Radiology, Jefferson Radiology, Hartford Hospital, 85 Seymour St, Ste 200, Hartford, CT 06106
    • P.C.M. is a paid consultant for Sirtex Medical.
    • Corresponding Author InformationAddress correspondence to P.C.M.
    • ,
  • Clement J. Grassi, MD

      Affiliations

    • Department of Radiology, Boston Healthcare System, VAMC Boston, Boston, Massachusetts
    • ,
  • Sanjoy Kundu, MD

      Affiliations

    • Department of Medical Imaging, Scarborough General Hospital, Richmond Hill, Ontario, Canada
    • ,
  • Debra Ann Gervais, MD

      Affiliations

    • Department of Radiology, GI/GU Division, Massachusetts General Hospital, Boston, Massachusetts
    • ,
  • Donald L. Miller, MD

      Affiliations

    • Department of Radiology and Radiologic Sciences, Uniformed Services University of the Health Sciences and Department of Radiology, National Naval Medical Center, Bethesda, Maryland
    • ,
  • Robert B. Osnis, MD

      Affiliations

    • RADIA, Everett, Washington
    • ,
  • Darren W. Postoak, MD

      Affiliations

    • Department of Radiology, University of Florida, Gainesville, Florida
    • ,
  • Dheeraj K. Rajan, MD

      Affiliations

    • Department of Medical Imaging, Division of Vascular and Interventional Radiology, University of Toronto, University Health Network, Toronto, Ontario, Canada
    • ,
  • David Sacks, MD

      Affiliations

    • Department of Interventional Radiology, The Reading Hospital and Medical Center, West Reading, Pennsylvania
    • ,
  • Marc S. Schwartzberg, MD

      Affiliations

    • Radiology Associates of Central Florida, Mt Dora, Florida
    • ,
  • Darryl A. Zuckerman, MD

      Affiliations

    • Mallinckrodt Institute of Radiology, St Louis, Missouri
    • ,
  • John F. Cardella, MD

      Affiliations

    • Geisinger System Radiology, Geisinger Health System, Danville, Pennsylvania
    • ,
  • Standards of Practice Committee with Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Endorsement

Received 18 November 2008 ,Accepted 24 November 2008.

References 

  1. Fink A, Kosefcoff J, Chassin M, Brook RH. Consensus methods: characteristics and guidelines for use. Am J Public Health. 1984;74:979–998
  2. Hyers TM, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest. 2001;119(1 suppl):176S–193S
  3. O'Grady JG, Alexander GJM, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–445
  4. Lee WM. Acute liver failure. N Engl J Med. 1993;329:1862–1872
  5. Pilsczek FH, Rifkin WD, Walerstein S. Overuse of prothrombin and partial thromboplastin coagulation tests in medical inpatients. Heart Lung. 2005;34:402–405
  6. Clauss A. A rapid physiological coagulation method for the determination of fibrinogen. Acta Haematol. 1957;17:237–240
  7. Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost. 1990;16:1–20
  8. Hellstern P, Muntean W, Schramm W, Seifried E, Solheim B. Practical guidelines for the clinical use of plasma. Thromb Res. 2002;107(suppl 1):S53
  9. Escobar MA. Reversal of coumarin-induced over-anticoagulation. Br J Haematol. 2002;118:925–926discussion 926.
  10. Wilson SE, Douketis JD, Crowther MA. Treatment of warfarin-associated coagulopathy: a physician survey. Chest. 2001;120:1972–1976
  11. Jacobs LG, Nusbaum N. Perioperative management and reversal of antithrombotic therapy. Clin Geriatr Med. 2001;17:189–202
  12. O'Connell BA, Lee EJ, Schiffer CA. The value of 10-minute post transfusion platelet counts. Transfusion. 1988;26:66–67
  13. Butterworth J, Lin YA, Prielipp RC, Bennett J, Hammon JW, James RL. Rapid disappearance of protamine in adults undergoing cardiac operation with cardiopulmonary bypass. Ann Thorac Surg. 2002;74:1589–1595
  14. Butterworth J, Lin YA, Prielipp R, Bennett J, James R. The pharmacokinetics and cardiovascular effects of a single intravenous dose of protamine in normal volunteers. Anesth Analg. 2002;94:514–522
  15. Brooks JC. Noncardiogenic pulmonary edema immediately following rapid protamine administration. Ann Pharmacother. 1999;33:927–930
  16. Wright SJ, Murray WB, Hampton WA, Hargovan H. Calculating the protamine-heparin reversal ratio: a pilot study investigating a new method. J Cardiothorac Vasc Anesth. 1993;7:416–421
  17. Lowenstein E. Lessons from studying an infrequent event: adverse hemodynamic response associated with protamine reversal of heparin anticoagulation. J Cardiothorac Anesth. 1989;3:99–107
  18. Ansell J, Hirsh J, Poller L, et al. The pharmacology and management of the vitamin K antagonists. Chest. 2004;126(suppl 3):204S–233S
  19. Raj G, Kumar R, McKinney WP. Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione. Arch Intern Med. 1999;159:2721–2724
  20. Byrd DC, Stephens MA, Hamann GL, Dorko C. Subcutaneous phytonadione for reversal of warfarin-induced elevation of the international normalized ratio. Am J Health Syst Pharm. 1999;56:2312–2315
  21. Konkle B. Percutaneous interventions in the coagulopathic patient. Semin Intervent Radiol. 2005;22:88–94
  22. Pusateri AE, Park MS. Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma. Critical Care. 2005;9(suppl 5):S15–S24
  23. Mannucci PM, Ruggeri Z, Pareti F, Capitanio A. 1-deamino-8-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands disease. Lancet. 1977;1:869–872
  24. Mannucci PM, Bettega D, Cattaneo M. Patterns of development of tachphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP). Br J Haematol. 1992;82:87–93
  25. Mannucci PM. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood. 1988;72:1449–1455
  26. Dzik W, Rao A. Why do physicians request fresh frozen plasma?. Transfusion. 2004;44:1393
  27. Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland D, Murphy MF. Is fresh frozen plasma clinically effective? (A systematic review of randomized controlled trials). Br J Haematol. 2004;126:1139
  28. Segal JB, Dzik WH. Transfusion Medicine/Hemostasis Clinical Trials Network (Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review). Transfusion. 2005;45:1413–1425
  29. Sawyerr AM, McCormick PA, Tennyson GS, et al. A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation. J Hepatol. 1993;17:81–85
  30. Darcy MD, Kanterman RY, Kleinhoffer MA, et al. Evaluation of coagulation tests as predictors of angiographic bleeding complications. Radiology. 1996;198:741–744
  31. Ewe K. Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci. 1981;26:388–393
  32. Fisher NC, Mutimer DJ. Central venous cannulation in patients with liver disease and coagulopathy: a prospective audit. Intensive Care Med. 1999;25:5
  33. Doerfler ME, Kaufman B, Goldenberg AS. Central venous catheter placement in patients with disorders of hemostasis. Chest. 1996;110:185–188
  34. Stellato TA, Gauderer MW, Lazarus HM, et al. Percutaneous isoelastic catheter insertion in patients with thrombocytopenia. Cancer. 1985;56:2691–2693
  35. Morado M, Jimenez-Yuste V, Villar A, et al. Complications of central venous catheters in patients with haemophilia and inhibitors. Haemophilia. 2001;7:551–556
  36. Stecker M, Johnson M, Ying J, et al. Time to hemostasis after traction removal of tunneled cuffed central venous catheters. J Vasc Interv Radiol. 2007;18:1232–1239
  37. Martin JH, Rosser CJ, Linebach RF, McCullough DL, Assimos DG. Are coagulation studies necessary before percutaneous nephrostomy?. Tech Urol. 2000;6:205–207
  38. Zagoria RJ, Dyer RB. Do's and don'ts of percutaneous nephrostomy. Acad Radiol. 1999;6:370–377
  39. Platelet transfusion therapy (National Institutes of Health Consensus Conference). Transfusion Med Rev. 1987;1:195–200
  40. Norfolk DR, Ancliffe PJ, Contreras M, et al. Consensus conference on platelet transfusion (Royal College of Physicians of Edinburgh, 27–28 November 1997). Br J Haematol. 1998;101:609–617
  41. Bishop JF, Schiffer CA, Aisner J, et al. Surgery in acute leukemia: a review of 167 operations in thrombocytopenic patients. Am J Hematol. 1987;26:147–155
  42. Chu DZJ, Shivshanker K, Stroehlein JR, et al. Thrombocytopenia and gastrointestinal hemorrhage in the cancer patient: prevalence of unmasked lesions. Gastrointest Endosc. 1983;29:269–272
  43. Weiss SM, Hert RC, Gianola FJ, et al. Complications of fiberoptic bronchoscopy in thrombocytopenic patients. Chest. 1993;104:1025–1028
  44. Schiffer CA, Anderson KC, Bennett CL, et al. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001;19:1519–1538
  45. McVay PA, Toy PT. Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. Am J Clin Pathol. 1990;94:747–753
  46. Wallace M, Narvios A, Lichtiger B, et al. Transjugular liver biopsy in patients with hematologic malignancy and severe thrombocytopenia. J Vasc Interv Radiol. 2003;14:323–327
  47. Ray CEJ, Shenoy SS. Patients with thrombocytopenia: outcome of radiologic placement of central venous access devices. Radiology. 1997;204:97–99
  48. Edelson RN, Chernik NL, Posner JB. Spinal subdural hematomas complicating lumbar puncture. Arch Neurol. 1974;31:134–137
  49. Breuer AC, Tyler R, Marzewski DJ, et al. Radicular vessels are the most probable source of needle induced blood in lumbar puncture. Cancer. 1982;49:2168–2172
  50. Howard SC, Gajjar A, Ribeiro RC, et al. Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia. JAMA. 2000;284:2222–2224
  51. Vavricka SR, Walter RB, Irani S, Halter J, Schanz U. Safety of lumbar puncture for adults with acute leukemia and restrictive prophylactic platelet transfusion. Ann Hematol. 2003;82:570–573
  52. Fox KA, Mehta SR, Peters R, et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non–ST-elevation acute coronary syndrome: the Clopidogrel in Unstable Angina to Prevent Recurrent Ischemic Events (CURE) Trial. Circulation. 2004;110:1202–1208
  53. Maier C, Gleim M, Weiss T, Stachetzki U, Nicolas V, Zenz M. Severe bleeding following lumbar sympathetic blockade in two patients under medication with irreversible platelet aggregation inhibitors. Anesthesiology. 2002;97:740–743
  54. Hussain N, Alsulaiman R, Burtin P, et al. The safety of endoscopic sphincterotomy in patients receiving antiplatelet agents: a case-control study. Alimentary Pharmacol Ther. 2007;25:579–584
  55. Schafer AI. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol. 1995;35:209–219
  56. Schafer AL. Effects of nonsteroidal anti-inflammatory therapy on platelets. Am J Med. 1999;106(suppl 5b):25S–36S

PII: S1051-0443(08)01094-4

doi: 10.1016/j.jvir.2008.11.027

Journal of Vascular and Interventional Radiology
Volume 20, Issue 7, Supplement , Pages S240-S249 , July 2009

Article Tools